Illimis Therapeutics jobs and careers
As of October 24, 2026, Illimis Therapeutics has no open roles listed.
About Illimis Therapeutics
Illimis Therapeutics is a platform-based Korean biotech company developing a chimeric fusion protein platform for neurodegenerative diseases such as Alzheimer’s. Our platform is differentiated by its ability to address the concerns of antibody-induced neuroinflammation and subsequent ARIA (Amyloid-Related Imaging Abnormalities) often observed from existing antibody drugs that utilize FcR-mediated phagocytosis of microglia, by utilizing TAM receptor, a novel phagocytic receptor expressed on the surface of glial cells.
- Founded
- 2021
- Employees
- 11 to 50
Leadership
The top of Illimis Therapeutics's org chart, with how many people report into each leader.
Sanghoon Park
Co-founder & CEO
Jobs at Illimis Therapeutics
No open positions right now. Explore more companies on TheJobsMap.
Illimis Therapeutics jobs: common questions
- Is Illimis Therapeutics hiring right now?
- Illimis Therapeutics has no open roles listed as of October 24, 2026. Roles appear here as soon as they are posted on Illimis Therapeutics's careers site.
- Who leads Illimis Therapeutics?
- Sanghoon Park, Co-founder & CEO, is at the top of Illimis Therapeutics's org chart.
- How do I apply for a job at Illimis Therapeutics?
- Pick a role on Illimis Therapeutics's TheJobsMap page and select Apply. Every listing links to the original posting on Illimis Therapeutics's own careers site, so you apply directly with the employer.